Company news
Sernova Biotherapeutics Inc news in 2020
Sernova Biotherapeutics Inc's news releases, calls and decks from 2020, newest first.
Sernova to Present at H.C. Wainwright BioConnect 2021 Conference
December 18, 2020
(PODCAST) Sernova's Visibility Increases Ahead of Holidays
December 16, 2020
Sernova Corp. Responds to Market Activity
December 11, 2020
Sernova Medical Advances Gain Media Attention
December 3, 2020
Sernova Announces Clinical Trial Investigator Presentation at the ASTS 21st Winter Symposium
November 30, 2020
Sernova Provides Clinical Update on U.S. Phase I/II Cell Pouch(TM) Trial for Type 1 Diabetes
November 18, 2020
Sernova Announces 3-Month Extension of Warrants
October 30, 2020
(Exclusive) Sernova Presents at TSX Life Sciences Investor Day: Available Now!
October 29, 2020
Sernova to Present at TSX Life Sciences Investor Day
October 27, 2020
Sernova to Present at Virtual BIO Investor Forum
September 24, 2020
Sernova Closes Oversubscribed Private Placement and Accelerates Development Programs
September 23, 2020
Sernova to Participate in Cell and Gene Therapies for Chronic Conditions Panel at the Virtual 2020 Cell & Gene Meeting on the Mesa Conference
September 10, 2020
Sernova Announces Up to $3 Million Private Placement Financing with a Lead Order of $2 Million
September 9, 2020
Sernova Enters into Exclusive Worldwide License Agreement with University of Miami for Therapeutic Cell Immune Protection Technologies
August 4, 2020
Dr. Anke M. Schulte Joins Sernova Global Advisory Board
July 16, 2020
Sernova Highlights Positive Results Presented at the American Diabetes Association's Virtual 80th Scientific Sessions
June 18, 2020
Sernova Completes Acquisition of Cellular Local Immune Protection Technology
June 15, 2020
Sernova to Acquire Cellular Local Immune Protection Technology Accelerating Expansion of its Regenerative Medicine Therapeutics Platform
June 8, 2020
Sernova to Present Clinical Validation of the Cell Pouch as a Viable, Safe Site for Diabetes Cell Therapy at the American Diabetes Association's Virtual 80th Scientific Sessions
June 3, 2020
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A
May 29, 2020
Sernova Announces Change of Location of Annual Meeting of Shareholders
May 26, 2020
Sernova Highlights Achievements of the HemAcure Hemophilia Cell Therapy Program Presented at ASGCT
May 19, 2020
Sernova Announces Presentation of HemAcure Hemophilia Program Results at 23rd Annual Meeting of the American Society of Gene and Cell Therapy
May 12, 2020
Sernova Advances Annual General Meeting and CEO Teleconference to Friday May 29
April 27, 2020
Important COVID-19 Safety Measures for Sernova's 2020 Annual Meeting of Shareholders
April 21, 2020
Sernova Provides Corporate Update and Outlook for 2020
March 24, 2020
Sernova to Present Corporate Update at Noble Capital Markets Investor Conference
February 17, 2020
Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes
February 13, 2020
Sernova Announces Positive DSMB Review and Recommendation for Continuation of Phase I/II Diabetes Clinical Trial of Cell Pouch(TM)
February 10, 2020
Decks in 2020
- Sernova — Cell and Gene Meeting on the Mesa 2020
Conference · 26 slides · October 2020